EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Journal of Clinical Pharmacology

Description
Official Publication of the American College of Clinical Pharmacology

 

Status
active
Indexing
Biological Abstracts; Biosciences Citation Index; BIOSIS Previews; CAB Abstracts Database; Chemical Abstracts; ChemSciences Citation Index; CINAHL database and CUMULATIVE INDEX TO NURSING AND ALLIED HEALTH LITERATURE; Clinical Medicine Citation Index; Current Contents: Clinical Medicine; Current Contents: Life Sciences; EMBASE/Excerpta Medica; Global Health; Index Medicus; InfoTrac (full text); International Pharmaceutical Abstracts; MEDLINE; Ovid (full text); Science Citation Index; Science Citation Index Expanded (Web of Science); Scopus
Subject

Source type
Journal
Publisher
ISBN ISSN
0091-2700
E ISSN
1552-4604
First volume
1
Last volume
48+
Publish city
Thousand Oaks, Calif.
Homepage
Description
For 45 years, clinical pharmacologists, clinical and pharmaceutical researchers, drug development specialists, physicians, nurses, and other medical professionals have relied on The Journal of Clinical Pharmacology for original research, special reviews, commentaries, and case reports on all phases of drug development from absorption, disposition, metabolism, excretion interactions, and preferred uses through post-marketing evaluations.

The Journal of Clinical Pharmacology features studies such as:
  • Mechanism of action for drugs
  • How dosage level affects absorption, metabolism, and excretion
  • The efficacy and benefits of drugs and under what conditions
  • How drugs interact with already approved drugs
  • How drugs alter the disease process
  • Long term effectiveness and impact of specific drugs on a patient’s quality of life
  • Adverse effects/reactions and drug interactions both for healthy populations and special populations such as children, the elderly, and women
  • Cost-effectiveness of drug therapy, especially compared to standard treatment or other new therapies
  • New and improved treatment and research methods from chemical, toxicological, pharmacological, and clinical studies

The Journal provides physicians and pharmacologists with well-written, original research on a broad range of topics related to:

  • Analgesia
  • Behavioral Pharmacology
  • Biochemical Pharmacology
  • Drug Development
  • Education
  • Cardiovascular Pharmacology
  • Chemotherapy
  • Immunopharmacology
  • Molecular Pharmacology
  • Neuropharmacology
  • Pediatric Pharmacology
  • Pharmacoeconomics
  • Pharmacoepidemiology
  • Pharmacodynamics
  • Pharmacokinetics
  • Toxicology











Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )